Jazz Pharmaceuticals(JAZZ)
$236.45-11.32 (-4.57%)
JAZZ
Jazz Pharmaceuticals earnings date
$236.45
At close:-11.32 (-4.57%)
Want to see JAZZ full AI Analyst Report?
Jazz Pharmaceuticals (JAZZ) Q3 2022 Earnings Report
1,946 Followers
JAZZ Q3 2022 EPS Results
- Actual EPS
- $5.17
- Consensus EPS
- $4.66
- Beat/Miss
- Beat by +$0.51
- One Year Ago EPS
- $4.20
JAZZ Q3 2022 Revenue Results
- Actual Revenue
- $940.65M
- Expected Revenue
- $939.98M
- Beat/Miss
- Beat by +$677.00K
- YoY Revenue Growth
- +12.23%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/09/2022
- Time
- After Close
- Conference Call
- Wednesday, November 9, 2022
JAZZ Upcoming Earnings
Jazz Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
JAZZ Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
JAZZ Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | 6.96- | 6.64 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -4.03-3.88 | 8.13 | -147.72% (-12.01) | |
| Aug 03, 2026 | 2026 (Q2) | 6.175.71 | -8.25 | 169.21% (+13.96) | |
| May 05, 2026 | 2026 (Q1) | 4.646.34 | 1.68 | 277.38% (+4.66) | |
| Feb 24, 2026 | 2025 (Q4) | 6.526.64 | 6.6 | 0.61% (+0.04) | |
| Nov 05, 2025 | 2025 (Q3) | 5.958.13 | 6.61 | 23.00% (+1.52) | |
| Aug 05, 2025 | 2025 (Q2) | -7.61-8.25 | 5.3 | -255.66% (-13.55) | |
| May 06, 2025 | 2025 (Q1) | 4.661.68 | 2.68 | -37.31% (-1.00) | |
| Feb 25, 2025 | 2024 (Q4) | 5.866.60 | 5.02 | 31.47% (+1.58) | |
| Nov 06, 2024 | 2024 (Q3) | 5.506.61 | 4.84 | 36.57% (+1.77) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


